Vipin M. Vashishtha Profile picture
May 4, 2021 9 tweets 6 min read Read on X
Have we reached to the peak of 2nd #Covid wave in India? May be, yes! Its already 2.5 months in to it. Most badly affected countries peaked within 1.5-3 months of onset of a new surge. Is it too early to comment? 1/
More interesting would be to see which way our curve goes: the UK/Israel or the US way! While both UK/Israel took 1.5-2 months to flatten their curves w/ strict lockdowns & aggressive vaccination, US had a long plateau (>3.5 months) 2/
However, there is heterogeneity in caseloads: While states like MH, UP, CG, PB, DL are showing ⬇️ in case load, some southern & eastern states (KA, KL, AP, TN, WB, ) still reporting cases in high numbers! What is driving Covid in these states? 3/ indiatoday.in/coronavirus-ou…
Different variants (VOC) are circulating in diff states of India. While it is #B1617 is in MS & neighboring states, #B117 in PB, DL & northern states, Delhi & #B1618 in WB & eastern states outbreak.info/situation-repo… 4/
Now, a new variant having #N440K spike substitution is believed to be behind the sudden rise of cases in southern India, particularly in KA, KL, AL & Telangana. Some believe it is believed to be 15 times more lethal than the earlier ones 5/ biorxiv.org/content/10.110…
So, what lies in store for #India? The few key factors that may extend India's suffering for a prolonged period:
1-lack of strict #lockdowns: having halfway yo-yo lockdowns are not the answer!
2-sluggish #inoculation drive: still only 2% of the population received 2-doses! 6/
3-rampant circulation of #variants: not sure which one is the main driver!
4-limited #sequencing: only 1% of isolates sequenced!
5-modestly efficacious #vaccines: unlike the other 3 countries
6-lack of #effectiveness data on currently employed vaccines: so, driving blindly! 7/
What could be the saving grace? Hoping the rapid descent follows the explosive ascent! And the virus, mutating at a staggering pace, might be heading for an evolutionary cliff all on its own. Amen! 8/
bbc.com/future/article…
One interesting thing to note: All the three countries had 3 waves, the last surge the severest!

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Vipin M. Vashishtha

Vipin M. Vashishtha Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @vipintukur

May 13
A new study suggests that
#LongCOVID patients had significantly more dilated capillaries, microhemorrhages, abnormal capillary shapes (neoangiogenesis) and lower capillary density than both recovered COVID patients without LongCOVID and healthy controls. 1/ Image
In this multicenter Italian study, researchers used nailfold videocapillaroscopy (NVC) to identify microvascular damage in Long COVID patients up to 18 months after infection. 2/ Image
Comparing NVC images in patients who had NVC before COVID infection and after COVID infection confirmed new vascular damage following infection. 3/ Image
Read 4 tweets
May 5
A new study shows that coronavirus spike proteins can trigger mast cell degranulation by binding to cellular receptors and activating the Src/PI3K/AKT signaling pathway, leading to increased calcium levels and mast cell granule release. 1/ Image
The activation and degranulation of mast cells (MCs), triggered by a variety of viruses, are intricately linked to viral pathogenesis. However, the precise mechanism underlying virus-induced MC degranulation remains largely unknown. 2/ Image
In this study, researchers demonstrate the ubiquity of coronavirus-induced MC degranulation and investigate the intracellular signaling pathways that mediate this process. 3/ Image
Read 7 tweets
May 5
Tiny RNA molecule may hold the key to treating knee osteoarthritis!

A NEW discovery could pave the way for new breakthroughs in detecting & treating the disease. Researchers identified a circulating microRNA, miR-126-3p, a mechanistic biomarker of osteoarthritis of knee 1/ Image
MiR-126-3p plays a role in reducing blood vessel formation and reducing the severity of knee osteoarthritis, making it not just a signal of disease—but potentially a contributor to it. 2/ Image
Now that scientists are aware of miR-126-3p, they can develop blood tests to detect osteoarthritis of the knee and therapeutics for slowing or even stopping progression. 3/ Image
Read 6 tweets
Apr 30
A new preprint validated earlier findings that genetic factors strongly influence who develops Long COVID, using data from both U.S. (All of Us) and U.K. (Sano GOLD) cohorts with diverse ancestries. 1/ Image
Over 90% of genes identified in the original study were also associated with #LongCOVID in the U.S. population including in Black and Hispanic groups. 2/
These results confirm that combinatorial genetic analysis can uncover more risk genes than traditional Genome-wide association studies (GWAS) and support the continued exploration of drug repurposing candidates for LongCOVID treatment. 3/ Image
Read 6 tweets
Apr 30
A team of researchers has launched a global clinical trial to evaluate two repurposed anti-inflammatory drugs #upadacitinib and #pirfenidone—approved for treating arthritis and lung disease, respectively as potential treatments for #LongCOVID. 1/ Image
he two drugs were selected using artificial intelligence (AI) from over 5,400 proteins linked to LongCOVID, offering a promising shortcut to treatment by targeting 13 shared biological pathways.  2/ Image
Despite the global prevalence of longCOVID, patients report different symptoms & their presentation can be influenced by where they happen to live. 3/ Image
Read 4 tweets
Apr 29
A group from SUNY Buffalo developed a nanoparticle vaccine candidate that displays recombinant H5 and N1 proteins from the highly pathogenic avian influenza H5N1 clade 2.3.4.4b on liposomes. 1/ Image
The widespread transmission of highly pathogenic avian H5N1 influenza, clade 2.3.4.4b, in wild and livestock mammals with isolated human cases has heightened concerns for zoonotic outbreak, necessitating vaccine readiness. 2/ Image
Here, the researchers assess whether recombinant H5 hemagglutinin and N1 neuraminidase proteins can confer protection from disease when antigens are presented as an adjuvanted nanoparticle vaccine. 3/ Image
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(